BTX-A Treatment for Palmar Hyperhidrosis

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

November 30, 2012

Conditions
Primary Focal Hyperhidrosis of the Hands
Interventions
DRUG

BTX-A

100 units of BTX-A will be delivered subject's hand via iontophoresis and standard of care intradermal injection of 100 units BTX-A will be delivered to the contra-lateral hand

Trial Locations (1)

53716

University of Wisconsin-Madison, Madison

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

collaborator

Mattioli

UNKNOWN

lead

University of Wisconsin, Madison

OTHER